Sclerosis  >>  opicinumab (BIIB033)  >>  Phase 1
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
opicinumab (BIIB033) / Biogen
NCT01244139: Safety Study of BIIB033 in Subjects With Multiple Sclerosis

Checkmark ACTRIMS-ECTRIMS 2014: MS
Sep 2014 - Sep 2014: ACTRIMS-ECTRIMS 2014: MS
Checkmark ECTRIMS 2013: Multiple sclerosis
Sep 2013 - Sep 2013: ECTRIMS 2013: Multiple sclerosis
Checkmark Data (MS)
More
Completed
1
47
US
BIIB033, Placebo
Biogen
Relapsing-Remitting Multiple Sclerosis, Multiple Sclerosis
04/12
04/12

Download Options